Mette S. Janas

1.2k total citations · 1 hit paper
17 papers, 873 citations indexed

About

Mette S. Janas is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mette S. Janas has authored 17 papers receiving a total of 873 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Internal Medicine, 5 papers in Cardiology and Cardiovascular Medicine and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mette S. Janas's work include Venous Thromboembolism Diagnosis and Management (7 papers), Central Venous Catheters and Hemodialysis (4 papers) and Neurogenesis and neuroplasticity mechanisms (4 papers). Mette S. Janas is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (7 papers), Central Venous Catheters and Hemodialysis (4 papers) and Neurogenesis and neuroplasticity mechanisms (4 papers). Mette S. Janas collaborates with scholars based in Denmark, United States and Netherlands. Mette S. Janas's co-authors include Pieter W. Kamphuisen, Guy Meyer, Mikala F. Jarner, Rupert Bauersachs, Alok A. Khorana, Agnes Lee, K. M�llg�rd, Richard S. Nowakowski, Kjeld Møllgård and Karsten Schmidt and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Blood.

In The Last Decade

Mette S. Janas

17 papers receiving 859 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer

2015 452 citations Agnes Lee, Pieter W. Kamphuisen et al. JAMA profile →

Peers

Countries citing papers authored by Mette S. Janas

Since Specialization

Citations

This map shows the geographic impact of Mette S. Janas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mette S. Janas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mette S. Janas more than expected).

Fields of papers citing papers by Mette S. Janas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mette S. Janas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mette S. Janas. The network helps show where Mette S. Janas may publish in the future.

Co-authorship network of co-authors of Mette S. Janas

This figure shows the co-authorship network connecting the top 25 collaborators of Mette S. Janas. A scholar is included among the top collaborators of Mette S. Janas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mette S. Janas. Mette S. Janas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Renal Impairment, Recurrent Venous Thromboembolism and Bleeding in Cancer Patients with Acute Venous Thromboembolism—Analysis of the CATCH Study 2018 ·Thrombosis and Haemostasis ·Agnes Lee, Pieter W. Kamphuisen, Guy Meyer, Mette S. Janas, Mikala F. Jarner, Alok A. Khorana, Rupert Bauersachs, (unknown)	37
2	Tissue Factor As a Predictor of Recurrent Venous Thromboembolism in Malignancy: Biomarker Analyses of the CATCH Trial 2017 ·Journal of Clinical Oncology ·Alok A. Khorana, Pieter W. Kamphuisen, Guy Meyer, Rupert Bauersachs, Mette S. Janas, Mikala F. Jarner, Agnes Lee	48
3	Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer breakdown → 2015 ·JAMA ·Agnes Lee, Pieter W. Kamphuisen, Guy Meyer, Rupert Bauersachs, Mette S. Janas, Mikala F. Jarner, Alok A. Khorana, (unknown)	452
4	Clinical predictors of recurrent venous thromboembolism (VTE) in cancer patients from a randomized trial of long-term tinzaparin versus warfarin for treatment: The CATCH study. 2015 ·Journal of Clinical Oncology ·Alok A. Khorana, Rupert Bauersachs, Pieter W. Kamphuisen, Guy Meyer, Mette S. Janas, Mikala F. Jarner, Agnes Y. Lee, (unknown)	11
5	A Randomized Trial of Long-Term Tinzaparin, a Low Molecular Weight Heparin (LMWH), Versus Warfarin for Treatment of Acute Venous Thromboembolism (VTE) in Cancer Patients - the CATCH Study 2014 ·Blood ·Agnes Lee, Pieter W. Kamphuisen, Guy Meyer, Rupert Bauersachs, Mette S. Janas, Mikala F. Jarner, Alok A. Khorana	21
6	CATCH: a randomised clinical trial comparing long-term tinzaparin versus warfarin for treatment of acute venous thromboembolism in cancer patients 2013 ·BMC Cancer ·Agnes Lee, Rupert Bauersachs, Mette S. Janas, Mikala F. Jarner, Pieter W. Kamphuisen, Guy Meyer, Alok A. Khorana	65
7	CATCH: A randomized trial comparing tinzaparin versus warfarin for treatment of acute venous thromboembolism (VTE) in cancer patients. 2012 ·Journal of Clinical Oncology ·Agnes Y. Lee, Rupert Bauersachs, Mette S. Janas, Mikala F. Jarner, Pieter W. Kamphuisen, Guy Meyer, Luis Paz‐Ares, Alok A. Khorana, (unknown)	11
8	Epidermal growth factor receptor expression analysis in chemotherapy-naive patients with advanced non-small-cell lung cancer treated with gefitinib or placebo in combination with platinum-based chemotherapy 2008 ·Journal of Cancer Research and Clinical Oncology ·Giuseppe Giaccone, Renee Iacona, Abderrahim Fandi, Mette S. Janas, Judith Ochs, Roy S. Herbst, David H. Johnson	9
9	P-616 EGFR expression in non-small-cell lung cancer: interobserver reproducibility of visually interpreted EGFR immunohistochemical staining 2003 ·Lung Cancer ·Mette S. Janas, Wilbur A. Franklin, Karsten Schmidt, (unknown)	1
10	O-242 Gefitinib (‘Iressa’, ZD1839) monotherapy for pretreated advanced non-small-cell lung cancer in IDEAL 1 and 2: tumor response is not clinically relevantly predictable from tumor EGFR membrane staining alone 2003 ·Lung Cancer ·(unknown), Mark G. Kris, Michael Wolf, Andrea Kay, Steven D. Averbuch, Jon Askaa, Mette S. Janas, Karsten Schmidt, Masahiro Fukuoka	85
11	Lung hypoplasia – a possible teratogenic effect of valproate 1998 ·Apmis ·Mette S. Janas, (unknown), (unknown), Niels Græm	3
12	Development of spinal cord in the isolated CNS of a neonatal mammal (the opossumMonodelphis domestica) maintained in longterm culture 1994 ·Journal of Neurocytology ·K. M�llg�rd, (unknown), Mette S. Janas, J. Mark Treherne, Norman R. Saunders, John G. Nicholls	27
13	Human fetuin/α2 HS glycoprotein in colloid and parenchymal cells in human fetal pituitary gland 1993 ·Histochemistry ·(unknown), Mette S. Janas, (unknown), Kjeld Møllgård	5
14	An immunocytochemical study of the innervation of developing human fetal teeth using protein gene product 9.5 (PGP 9.5) 1993 ·Archives of Oral Biology ·(unknown), Mette S. Janas, Kjeld Møllgård, (unknown)	39
15	NCAM as a differentiation marker of postmigratory immature neurons in the developing human nervous system 1992 ·International Journal of Developmental Neuroscience ·(unknown), Mette S. Janas, Elisabeth Bock, Kjeld Møllgård	8
16	Glial cell differentiation in neuron-free and neuron-rich regions 1991 ·Anatomy and Embryology ·Mette S. Janas, Richard S. Nowakowski, (unknown), K. M�llg�rd	26
17	Glial cell differentiation in neuron-free and neuron-rich regions 1991 ·Anatomy and Embryology ·Mette S. Janas, Richard S. Nowakowski, K. M�llg�rd	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact